Last updated on June 2019

BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

Brief description of study

The study is designed to compare the effects of BI 425809 compared to placebo in patients with cognitive impairment due to Alzheimer's Disease.

Clinical Study Identifier: NCT02788513

Find a site near you

Start Over

Axiom Research LLC

Colton, CA United States
  Connect »

Alliance for Wellness

Long Beach, CA United States
  Connect »

Anderson Clinical Research

Redlands, CA United States
  Connect »


Santa Ana, CA United States
  Connect »

MD Clinical

Hallandale Beach, FL United States
  Connect »

Galiz Research

Miami, FL United States
  Connect »

Stedman Clinical Trials

Tampa, FL United States
  Connect »

Bioclinica Research

The Villages, FL United States
  Connect »

Roper St. Francis Healthcare

Charleston, SC United States
  Connect »

The Memory Clinic

Bennington, VT United States
  Connect »

Diex Recherche

Sherbrooke, QC Canada
  Connect »


Helsinki, Finland
  Connect »

HOP Pellegrin

Bordeaux, France
  Connect »

HOP de Brabois

Vandoeuvre les Nancy, France
  Connect »

HOP des Charpennes

Villeurbanne, France
  Connect »

Katayama Medical Clinic

Okayama, Kurashiki, Japan
  Connect »

Royal Cornhill Hospital

Aberdeen, United Kingdom
  Connect »

Fulbourn Hospital

Cambridge, United Kingdom
  Connect »

Western General Hospital

Edinburgh, United Kingdom
  Connect »

Warneford Hospital

Oxford, United Kingdom
  Connect »

Sheffield Memory Service

Sheffield, United Kingdom
  Connect »

Kawashima Neurology Clinic

Kanagawa, Fujisawa, Japan
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.